Key result
Microglial IL-33 drives retinal neovascularization via ERK1/2-CREB and HIF-1α signaling.
Why the study?
Retinal ischemia activates microglia, and because IL-33 receptors are predominantly located in microglia, whether IL-33 modulates pro-angiogenic factors in retinal microglia during ischemic retinal diseases required investigation.
Does IL-33 modulate HIF-1α expression in microglia and regulate retinal neovascularization in ischemic retinal disease models?
Does IL-33 modulate HIF-1α expression in microglia and regulate retinal neovascularization in ischemic retinal disease models?
Answers are grounded in this paper and cite their sources.
Preclinical findings identify microglial IL-33-ERK1/2-CREB-HIF-1α signaling as a driver of ischemic retinal neovascularization, suggesting IL-33 antagonists as a potential therapeutic target for proliferative retinopathies.
BACKGROUND: The retina is sensitive to oxygen levels, and retinal ischemia plays a crucial role in retinal neovascularization (NV). Retinal ischemia triggers activation, proliferation, and migration of microglia, which might contribute to the pathogenesis of retinal NV. Because IL-33 (interleukin-33) receptors are predominantly located in microglia, we investigated whether IL-33 modulates pro-angiogenic factors in retinal microglia during ischemic retinal diseases. METHODS: We used a murine model of oxygen-induced retinopathy, human retinal microvascular endothelial cells, and HMC3 cells to study the role of microglia-specific IL-33 signaling on retinal NV. Using 3′ mRNA sequencing and Western blotting, we examined the IL-33 signaling pathways that contribute to IL-33-induced HIF-1α (hypoxia-inducible factor-1 alpha) expression. RESULTS: The results demonstrated that IL-33 regulates microglia activation in the ischemic retina, and deletion of microglia along with IL-33 leads to a reduction in retinal NV. Our results from 3′ mRNA sequencing show that IL-33 promotes the expression of HIF-1α in microglia. In addition, IL-33 not only induces the expression of HIF-1α at both the mRNA and protein levels but also facilitates its nuclear translocation. We observed an increase in the migration and sprouting of human retinal microvascular endothelial cells after treatment with supernatant derived from human microglia exposed to IL-33. Our findings demonstrate that IL-33 modulates HIF-1α expression in microglia through ERK1/2 (extracellular signal-regulated kinase 1 and 2)–CREB (cAMP-responsive element-binding protein) signaling, which regulates retinal NV in the ischemic retina. CONCLUSIONS: The present findings highlight the significance of IL-33 in modulating HIF-1α expression in microglia, which is pivotal in proliferative retinopathies, and suggest the exploration of IL-33 antagonists as a potential therapeutic approach for retinal NV.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied Retinal ischemia and retinal neovascularization. IL-33 signaling modulation / microglia and IL-33 deletion was evaluated on HIF-1α expression and retinal neovascularization. IL-33 modulates HIF-1α expression and nuclear translocation in microglia via ERK1/2-CREB signaling, and deletion of microglia with IL-33 reduces retinal neovascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: